|
1
|
Ostrom QT, Gittleman H, Truitt G, Boscia
A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2011–2015. Neuro Oncol. 20 (Suppl 4):iv1–iv86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Albain KS, Swann RS, Rusch VW, Turrisi AT
III, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara
DR, et al: Radiotherapy plus chemotherapy with or without surgical
resection for stage III non-small-cell lung cancer: A phase III
randomised controlled trial. Lancet. 374:379–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Cote DJ, Ascha M, Kruchko C and
Barnholtz-Sloan JS: Adult glioma incidence and survival by race or
ethnicity in the United States from 2000 to 2014. JAMA Oncol.
4:1254–1262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bralten LB and French PJ: Genetic
alterations in glioma. Cancers (Basel). 3:1129–1140. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohgaki H, Dessen P, Jourde B, Horstmann S,
Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM,
Maiorka PC, et al: Genetic pathways to glioblastoma: A
population-based study. Cancer Res. 64:6892–6899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng H, Ying H, Yan H, Kimmelman AC,
Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, et al: p53
and Pten control neural and glioma stem/progenitor cell renewal and
differentiation. Nature. 455:1129–1133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chou MY, Lin CH, Chao PL, Hung JC, Cruz SA
and Hwang PP: Stanniocalcin-1 controls ion regulation functions of
ion-transporting epithelium other than calcium balance. Int J Biol
Sci. 11:122–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayase S, Sasaki Y, Matsubara T, Seo D,
Miyakoshi M, Murata T, Ozaki T, Kakudo K, Kumamoto K, Ylaya K, et
al: Expression of stanniocalcin 1 in thyroid side population cells
and thyroid cancer cells. Thyroid. 25:425–436. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou H, Li YY, Zhang WQ, Lin D, Zhang WM
and Dong WD: Expression of stanniocalcin-1 and stanniocalcin-2 in
laryngeal squamous cell carcinoma and correlations with clinical
and pathological parameters. PLoS One. 9:e954662014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song H, Xu B and Yi J: Clinical
significance of stanniocalcin-1 detected in peripheral blood and
bone marrow of esophageal squamous cell carcinoma patients. J Exp
Clin Cancer Res. 31:352012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du YZ, Gu XH, Li L and Gao F: The
diagnostic value of circulating stanniocalcin-1 mRNA in non-small
cell lung cancer. J Surg Oncol. 104:836–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu G, Yang G, Chang B, Mercado-Uribe I,
Huang M, Zheng J, Bast RC, Lin SH and Liu J: Stanniocalcin 1 and
ovarian tumorigenesis. J Natl Cancer Inst. 102:812–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan KK, Leung CO, Wong CC, Ho DW, Chok
KS, Lai CL, Ng IO and Lo RC: Secretory stanniocalcin 1 promotes
metastasis of hepatocellular carcinoma through activation of JNK
signaling pathway. Cancer Lett. 403:330–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su J, Guo B, Zhang T, Wang K, Li X and
Liang G: Stanniocalcin-1, a new biomarker of glioma progression, is
associated with prognosis of patients. Tumour Biol. 36:6333–6339.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, He ZC, Zhang XN, Liu Q, Chen C, Zhu
Z, Chen Q, Shi Y, Yao XH, Cui YH, et al: Stanniocalcin-1 augments
stem-like traits of glioblastoma cells through binding and
activating NOTCH1. Cancer Lett. 416:66–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bowman RL, Wang Q, Carro A, Verhaak RG and
Squatrito M: GlioVis data portal for visualization and analysis of
brain tumor expression datasets. Neuro Oncol. 19:139–141. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gravendeel LA, Kouwenhoven MC, Gevaert O,
de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB,
Kloosterhof NK, et al: Intrinsic gene expression profiles of
gliomas are a better predictor of survival than histology. Cancer
Res. 69:9065–9072. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J,
Wang K, Wang Z, Nam Y, Jiang B, et al: Mutational landscape of
secondary glioblastoma guides MET-targeted trial in brain tumor.
Cell. 175:1665–1678.e18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verhaak RG, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stupp R, Mason WP, Van Den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pekmezci M, Rice T, Molinaro AM, Walsh KM,
Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G,
et al: Adult infiltrating gliomas with WHO 2016 integrated
diagnosis: Additional prognostic roles of ATRX and TERT. Acta
Neuropathol. 133:1001–1016. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen R, Mo Q, Schultz N, Seshan VE, Olshen
AB, Huse J, Ladanyi M and Sander C: Integrative subtype discovery
in glioblastoma using icluster. PLoS One. 7:e352362012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morokoff A, Ng W, Gogos A and Kaye AH:
Molecular subtypes, stem cells and heterogeneity: Implications for
personalised therapy in glioma. J Clin Neurosci. 22:1219–1226.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramirez YP, Weatherbee JL, Wheelhouse RT
and Ross AH: Glioblastoma multiforme therapy and mechanisms of
resistance. Pharmaceuticals (Basel). 6:1475–1506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kikuchi M, Nakano Y, Nambo Y, Haneda S,
Matsui M, Miyake Y, Macleod JN, Nagaoka K and Imakawa K: Production
of calcium maintenance factor stanniocalcin-1 (STC1) by the equine
endometrium during the early pregnant period. J Reprod Dev.
57:203–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du YZ, Gu XH, Cheng SF, Li L, Liu H, Hu LP
and Gao F: The oncogenetic role of stanniocalcin 1 in lung
adenocarcinoma: A promising serum candidate biomarker for tracking
lung adenocarcinoma progression. Tumour Biol. 37:5633–5644. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brantley KD, Kjaersgaard A, Cronin-Fenton
D, Yacoub R, Nielsen AS, Lauridsen KL, Hamilton-Dutoit S and Lash
TL: Stanniocalcin expression as a predictor of late breast cancer
recurrence. Cancer Epidemiol Biomarkers Prev. 27:653–659. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Qi Z, Zhou M, Yang W, Hu R, Li G,
Ma X and Zhang Z: Stanniocalcin1 promotes cell proliferation,
chemoresistance and metastasis in hypoxic gastric cancer cells via
Bcl2. Oncol Rep. 41:1998–2008. 2019.PubMed/NCBI
|
|
31
|
Leung CC and Wong CK: Effects of STC1
overexpression on tumorigenicity and metabolism of hepatocellular
carcinoma. Oncotarget. 9:6852–6861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shirakawa M, Fujiwara Y, Sugita Y, Moon
JH, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Mori M and Doki
Y: Assessment of stanniocalcin-1 as a prognostic marker in human
esophageal squamous cell carcinoma. Oncol Rep. 27:940–946. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li K, Dong D, Yao L, Dai D, Gu X and Guo
L: Identification of STC1 as an beta-amyloid activated gene in
human brain microvascular endothelial cells using cDNA microarray.
Biochem Biophys Res Commun. 376:399–403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Durukan Tolvanen A, Westberg JA,
Serlachius M, Chang AC, Reddel RR, Andersson LC and Tatlisumak T:
Stanniocalcin 1 is important for poststroke functionality, but
dispensable for ischemic tolerance. Neuroscience. 229:49–54. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ito Y, Zemans R, Correll K, Yang IV, Ahmad
A, Gao B and Mason RJ: Stanniocalcin-1 is induced by hypoxia
inducible factor in rat alveolar epithelial cells. Biochem Biophys
Res Commun. 452:1091–1097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Monteiro AR, Hill R, Pilkington GJ and
Madureira PA: The Role of Hypoxia in Glioblastoma Invasion. Cells.
6:E452017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yeung HY, Lai KP, Chan HY, Mak NK, Wagner
GF and Wong CK: Hypoxia-inducible factor-1-mediated activation of
stanniocalcin-1 in human cancer cells. Endocrinology.
146:4951–4960. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jensen RL: Brain tumor hypoxia:
Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a
therapeutic target. J Neurooncol. 92:317–335. 2009. View Article : Google Scholar : PubMed/NCBI
|
